Published in Metabolism on May 01, 1982
Perioperative management of a patient with thyroid hormone resistance who underwent total thyroidectomy for thyroid cancer. J Anesth (2012) 0.79
Hyperthyroidism due to inappropriate TSH secretion with associated hyperprolactinaemia--a case report and review of the literature. Postgrad Med J (1984) 0.75
Laboratory based study of undetectable thyroid stimulating hormone. J Clin Pathol (1989) 0.75
Incidence of early loss of pregnancy. N Engl J Med (1988) 9.21
The Colorado thyroid disease prevalence study. Arch Intern Med (2000) 7.84
Treatment guidelines for patients with hyperthyroidism and hypothyroidism. Standards of Care Committee, American Thyroid Association. JAMA (1995) 3.68
Prospective multicenter study of thyroiscarcinoma treatment: initial analysis of staging and outcome. National Thyroid Cancer Treatment Cooperative Study Registry Group. Cancer (1998) 3.55
A consensus report of the role of serum thyroglobulin as a monitoring method for low-risk patients with papillary thyroid carcinoma. J Clin Endocrinol Metab (2003) 3.24
Screening for mild thyroid failure at the periodic health examination: a decision and cost-effectiveness analysis. JAMA (1996) 2.30
A potential novel mechanism for precocious puberty in juvenile hypothyroidism. J Clin Endocrinol Metab (1995) 2.22
Comparison of administration of recombinant human thyrotropin with withdrawal of thyroid hormone for radioactive iodine scanning in patients with thyroid carcinoma. N Engl J Med (1997) 2.20
AACE/AAES medical/surgical guidelines for clinical practice: management of thyroid carcinoma. American Association of Clinical Endocrinologists. American College of Endocrinology. Endocr Pract (2001) 2.15
Transport of steroid hormones: binding of 21 endogenous steroids to both testosterone-binding globulin and corticosteroid-binding globulin in human plasma. J Clin Endocrinol Metab (1981) 2.07
Failure of perchlorate to inhibit Tc-99m isonitrile binding by the thyroid during myocardial perfusion studies. Clin Nucl Med (1991) 2.05
Antithyroid drugs. N Engl J Med (1984) 1.99
Radioiodine ablation of thyroid remnants after preparation with recombinant human thyrotropin in differentiated thyroid carcinoma: results of an international, randomized, controlled study. J Clin Endocrinol Metab (2005) 1.98
A comparison of recombinant human thyrotropin and thyroid hormone withdrawal for the detection of thyroid remnant or cancer. J Clin Endocrinol Metab (1999) 1.92
L-Thyroxine therapy in subclinical hypothyroidism. A double-blind, placebo-controlled trial. Ann Intern Med (1984) 1.88
Thyroid hormone regulates the mouse thyrotropin beta-subunit gene promoter in transfected primary thyrotropes. J Biol Chem (1989) 1.84
The use of antithyroid drugs in pregnancy and lactation. J Clin Endocrinol Metab (2001) 1.81
Do traditional symptoms of hypothyroidism correlate with biochemical disease? J Gen Intern Med (1997) 1.75
Clinical review 115: effect of thyroxine therapy on serum lipoproteins in patients with mild thyroid failure: a quantitative review of the literature. J Clin Endocrinol Metab (2000) 1.73
Subclinical hypothyroidism is mild thyroid failure and should be treated. J Clin Endocrinol Metab (2001) 1.72
Molecular diagnosis of residual and recurrent thyroid cancer by amplification of thyroglobulin messenger ribonucleic acid in peripheral blood. J Clin Endocrinol Metab (1998) 1.65
Lymphocytic (microscopic) colitis. Clinicopathologic study of 18 patients and comparison to collagenous colitis. Dig Dis Sci (1989) 1.65
Classification of biopsy-confirmed brain tumors using single-voxel MR spectroscopy. AJNR Am J Neuroradiol (1999) 1.64
Treatment guidelines for patients with thyroid nodules and well-differentiated thyroid cancer. American Thyroid Association. Arch Intern Med (1996) 1.57
Noninvasive evaluation of cardiac function in hypothyroidism. Response to gradual thyroxine replacement. N Engl J Med (1977) 1.55
Central nervous system side effects associated with zolpidem treatment. Clin Neuropharmacol (2000) 1.54
Thyroid hormone resistance syndromes. Am J Med (1993) 1.54
Living related kidney donors. A 14-year experience. Ann Surg (1986) 1.53
Decreased bone density in hyperprolactinemic women. N Engl J Med (1980) 1.53
Alteration of vitamin D metabolism in Mexican-Americans. J Bone Miner Res (1990) 1.53
Hypothyroidism-induced macroorchidism: use of a gonadotropin-releasing hormone agonist to understand its mechanism and augment adult stature. J Clin Endocrinol Metab (1995) 1.43
Secondary malignancy of the thyroid gland: a case report and review of the literature. Thyroid (1994) 1.41
Antithyroid drugs and radioiodine therapy: a grain of (iodized) salt. Ann Intern Med (1994) 1.38
Thyroid hormone treatment: new insights into an old therapy. JAMA (1989) 1.38
Congenital goiter and the development of metastatic follicular carcinoma with evidence for a leak of nonhormonal iodide: clinical, pathological, kinetic, and biochemical studies and a review of the literature. J Clin Endocrinol Metab (1981) 1.36
Subclinical hyperthyroidism and reduced bone density as a possible result of prolonged suppression of the pituitary-thyroid axis with L-thyroxine. Am J Med (1987) 1.34
Measuring early pregnancy loss: laboratory and field methods. Fertil Steril (1985) 1.34
Osteoporosis in men with hyperprolactinemic hypogonadism. Ann Intern Med (1986) 1.34
Transcriptional regulation of the thyrotropin subunit genes by thyroid hormone. J Biol Chem (1985) 1.33
Thyrotropin suppression and disease progression in patients with differentiated thyroid cancer: results from the National Thyroid Cancer Treatment Cooperative Registry. Thyroid (1998) 1.33
Endocrine disorders in men infected with human immunodeficiency virus. Am J Med (1988) 1.32
The effects of ketamine-xylazine anesthesia on cerebral blood flow and oxygenation observed using nuclear magnetic resonance perfusion imaging and electron paramagnetic resonance oximetry. Brain Res (2001) 1.29
Agranulocytosis associated with antithyroid drugs. Effects of patient age and drug dose. Ann Intern Med (1983) 1.29
Suppression of pituitary TSH secretion in the patient with a hyperfunctioning thyroid nodule. J Clin Invest (1973) 1.27
Pituitary-specific Gata2 knockout: effects on gonadotrope and thyrotrope function. Mol Endocrinol (2006) 1.27
Adrenoleukodystrophy. Endocrinol Metab Clin North Am (1991) 1.26
Family structure and depressive symptoms in men preceding and following the birth of a child. The Avon Longitudinal Study of Pregnancy and Childhood Study Team. Am J Psychiatry (1998) 1.25
The impact of age and gender on papillary thyroid cancer survival. J Clin Endocrinol Metab (2012) 1.25
Physical training improves skeletal muscle metabolism in patients with chronic heart failure. J Am Coll Cardiol (1993) 1.24
Spectrum of pituitary alterations with mild and severe thyroid impairment. J Clin Endocrinol Metab (1978) 1.24
Critical oxygen tension in rat brain: a combined (31)P-NMR and EPR oximetry study. Am J Physiol Regul Integr Comp Physiol (2000) 1.22
Sucralfate causes malabsorption of L-thyroxine. Am J Med (1994) 1.22
Enhancer-mediated high level expression of mouse pituitary glycoprotein hormone alpha-subunit transgene in thyrotropes, gonadotropes, and developing pituitary gland. Mol Endocrinol (1994) 1.20
Substrate cycling between gluconeogenesis and glycolysis in euthyroid, hypothyroid, and hyperthyroid man. J Clin Invest (1985) 1.20
Follicular variant of papillary thyroid carcinoma. A clinicopathologic study. Cancer (1994) 1.18
Signaling pathways responsible for fetal gene induction in the failing human heart: evidence for altered thyroid hormone receptor gene expression. Circulation (2001) 1.17
The effect of glucocorticoid administration on human pituitary secretion of thyrotropin and prolactin. J Clin Endocrinol Metab (1976) 1.15
Increased upper body and overall adiposity is associated with decreased sex hormone binding globulin in postmenopausal women. Int J Obes (1991) 1.14
In vitro MR imaging of hyaline cartilage: correlation with scanning electron microscopy. AJR Am J Roentgenol (2000) 1.14
BRAF T1796A transversion mutation in various thyroid neoplasms. J Clin Endocrinol Metab (2004) 1.14
Successful treatment of Cushing's syndrome with the glucocorticoid antagonist RU 486. J Clin Endocrinol Metab (1985) 1.14
Diseases of the thyroid gland. Clin Endocrinol Metab (1985) 1.13
Assessment of cerebral pO2 by EPR oximetry in rodents: effects of anesthesia, ischemia, and breathing gas. Brain Res (1995) 1.13
Evaluation of acromegaly by radioimmunoassay of somatomedin-C. N Engl J Med (1979) 1.13
High-dose itraconazole in the treatment of severe mycoses. Antimicrob Agents Chemother (1991) 1.12
Langerhans cell histiocytosis of the thyroid: a report of two cases and review of the literature. Thyroid (2001) 1.11
Hürthle cell neoplasms of the thyroid: are there factors predictive of malignancy? Ann Surg (1998) 1.11
Pituitary secretion of free alpha and beta subunit of human thyrotropin in patients with thyroid disorders. J Clin Endocrinol Metab (1975) 1.10
Bioavailability of albumin-bound testosterone. J Clin Endocrinol Metab (1985) 1.10
Thyroid-stimulating activity and chorionic gonadotropin. J Clin Invest (1974) 1.10
Policy decisions on endocrine disruptors should be based on science across disciplines: a response to Dietrich et al. Endocrinology (2013) 1.08
Use of nitroxides for assessing perfusion, oxygenation, and viability of tissues: in vivo EPR and MRI studies. Magn Reson Med (1996) 1.08
Reduction of plasma immunoreactive somatomedin C during fasting in humans. J Clin Endocrinol Metab (1981) 1.08
Elasticity of canine vocal fold tissue. J Speech Hear Res (1984) 1.07
Genetic control of renin activity in the submaxillary gland of the mouse. Proc Natl Acad Sci U S A (1977) 1.07
MED220/thyroid receptor-associated protein 220 functions as a transcriptional coactivator with Pit-1 and GATA-2 on the thyrotropin-beta promoter in thyrotropes. Mol Endocrinol (2006) 1.06
Oral gossypol in the treatment of metastatic adrenal cancer. J Clin Endocrinol Metab (1993) 1.05
Cellular energetics of dystrophic muscle. J Neurol Sci (1993) 1.05
Thyrotropin-induced hyperthyroidism: use of alpha and beta subunit levels to identify patients with pituitary tumors. J Clin Endocrinol Metab (1977) 1.05
Secretion of alpha subunit of glycoprotein hormones by pituitary adenomas. J Clin Endocrinol Metab (1976) 1.05
Clinical utility of posttreatment radioiodine scans in the management of patients with thyroid carcinoma. J Clin Endocrinol Metab (1994) 1.05
Assessment of the incremental value of recombinant thyrotropin stimulation before 2-[18F]-Fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography imaging to localize residual differentiated thyroid cancer. J Clin Endocrinol Metab (2009) 1.04
Complications of surgery in hypothyroid patients. Am J Med (1984) 1.03
Production of 1,25-dihydroxyvitamin D3 by human T cell lymphotrophic virus-I-transformed lymphocytes. J Clin Invest (1986) 1.03
Consistency and change in mothers' behavior toward young siblings. Child Dev (1986) 1.03
Purification of beta-core fragment from pregnancy urine and demonstration that its carbohydrate moieties differ from those of native human chorionic gonadotropin-beta. Endocrinology (1988) 1.02